P-032. Efficiency and safety of direct acting antivirals in chronic hepatitis C patients ınfected with genotype 2 and 3 in Turkey

INTRODUCTION: Genotypes 2 and 3 chronic hepatitis C (CHC) patients are less frequently seen than genotype 1 in Turkey. While these genotypes have had favorable treatment outcomes with interferon-based regimens, response rates are lower with direct acting antivirals (DAAs). We aimed to evaluate effic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Turk J Gastroenterol
Autori principali: Kurtaran, Behice, Sarıgül, Figen, Çabalak, Mehmet, Kaya, Sibel, Sarı, Nagehan Didem, Karsen, Hasan, Zerdali, Esra, Güner, Rahmet, Türker, Kamuran, Ince, Nevin, Tabak, Fehmi, Group, Hepcturkey Study
Natura: Artigo
Lingua:Inglês
Pubblicazione: Turkish Society of Gastroenterology 2019
Soggetti:
AASLD - TASL CONNECT REGIONAL MEETING, March 15–16, 2019 - İstanbul, Turkey
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021041/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2019.38
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi